1. Home
  2. AGNC vs GKOS Comparison

AGNC vs GKOS Comparison

Compare AGNC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGNC
  • GKOS
  • Stock Information
  • Founded
  • AGNC 2008
  • GKOS 1998
  • Country
  • AGNC United States
  • GKOS United States
  • Employees
  • AGNC N/A
  • GKOS N/A
  • Industry
  • AGNC Real Estate Investment Trusts
  • GKOS Medical/Dental Instruments
  • Sector
  • AGNC Real Estate
  • GKOS Health Care
  • Exchange
  • AGNC Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • AGNC 8.0B
  • GKOS 5.1B
  • IPO Year
  • AGNC 2008
  • GKOS 2015
  • Fundamental
  • Price
  • AGNC $8.85
  • GKOS $96.63
  • Analyst Decision
  • AGNC Buy
  • GKOS Strong Buy
  • Analyst Count
  • AGNC 10
  • GKOS 13
  • Target Price
  • AGNC $10.04
  • GKOS $155.00
  • AVG Volume (30 Days)
  • AGNC 43.0M
  • GKOS 1.0M
  • Earning Date
  • AGNC 04-21-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • AGNC 16.27%
  • GKOS N/A
  • EPS Growth
  • AGNC N/A
  • GKOS N/A
  • EPS
  • AGNC 0.40
  • GKOS N/A
  • Revenue
  • AGNC $584,000,000.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • AGNC $29.70
  • GKOS $27.84
  • Revenue Next Year
  • AGNC N/A
  • GKOS $27.99
  • P/E Ratio
  • AGNC $22.27
  • GKOS N/A
  • Revenue Growth
  • AGNC N/A
  • GKOS 21.85
  • 52 Week Low
  • AGNC $7.85
  • GKOS $77.91
  • 52 Week High
  • AGNC $10.85
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • AGNC 46.84
  • GKOS 50.06
  • Support Level
  • AGNC $8.52
  • GKOS $87.17
  • Resistance Level
  • AGNC $8.63
  • GKOS $98.86
  • Average True Range (ATR)
  • AGNC 0.41
  • GKOS 5.59
  • MACD
  • AGNC 0.07
  • GKOS 1.78
  • Stochastic Oscillator
  • AGNC 71.43
  • GKOS 88.89

About AGNC AGNC Investment Corp.

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: